| 3.1 |
12.5 |
GO:2000795 |
negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
| 1.2 |
4.9 |
GO:0051866 |
general adaptation syndrome(GO:0051866) |
| 1.1 |
9.0 |
GO:0090074 |
negative regulation of protein homodimerization activity(GO:0090074) |
| 1.0 |
3.0 |
GO:0001928 |
regulation of exocyst assembly(GO:0001928) |
| 1.0 |
10.9 |
GO:0010650 |
positive regulation of cell communication by electrical coupling(GO:0010650) positive regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900827) |
| 0.9 |
7.3 |
GO:0060164 |
regulation of timing of neuron differentiation(GO:0060164) |
| 0.9 |
4.3 |
GO:0048631 |
regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.8 |
2.5 |
GO:0007290 |
spermatid nucleus elongation(GO:0007290) |
| 0.8 |
2.4 |
GO:0042271 |
susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
| 0.6 |
4.3 |
GO:0031536 |
positive regulation of exit from mitosis(GO:0031536) |
| 0.5 |
4.5 |
GO:0010587 |
miRNA catabolic process(GO:0010587) |
| 0.5 |
1.4 |
GO:0042320 |
regulation of circadian sleep/wake cycle, REM sleep(GO:0042320) circadian sleep/wake cycle, REM sleep(GO:0042747) positive regulation of circadian sleep/wake cycle, sleep(GO:0045938) |
| 0.5 |
1.4 |
GO:0042663 |
regulation of endodermal cell fate specification(GO:0042663) |
| 0.4 |
1.2 |
GO:0030070 |
insulin processing(GO:0030070) |
| 0.4 |
2.7 |
GO:0034047 |
regulation of protein phosphatase type 2A activity(GO:0034047) |
| 0.4 |
3.4 |
GO:0035881 |
amacrine cell differentiation(GO:0035881) |
| 0.4 |
7.2 |
GO:0050650 |
chondroitin sulfate proteoglycan biosynthetic process(GO:0050650) |
| 0.3 |
4.3 |
GO:0009312 |
oligosaccharide biosynthetic process(GO:0009312) |
| 0.3 |
1.2 |
GO:1904565 |
response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.3 |
1.2 |
GO:0000415 |
negative regulation of histone H3-K36 methylation(GO:0000415) |
| 0.3 |
0.8 |
GO:0003162 |
atrioventricular node development(GO:0003162) |
| 0.3 |
0.8 |
GO:0015772 |
disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.3 |
1.1 |
GO:1904694 |
negative regulation of vascular smooth muscle contraction(GO:1904694) |
| 0.3 |
0.8 |
GO:2000297 |
negative regulation of synapse maturation(GO:2000297) |
| 0.2 |
5.1 |
GO:0008090 |
retrograde axonal transport(GO:0008090) |
| 0.2 |
0.7 |
GO:2000620 |
positive regulation of histone H4-K16 acetylation(GO:2000620) |
| 0.2 |
0.9 |
GO:0044565 |
dendritic cell proliferation(GO:0044565) |
| 0.2 |
0.7 |
GO:0036092 |
phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
| 0.2 |
0.7 |
GO:0032696 |
negative regulation of interleukin-13 production(GO:0032696) trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) odontoblast differentiation(GO:0071895) regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.2 |
5.7 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.2 |
1.8 |
GO:0061368 |
behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
| 0.2 |
2.0 |
GO:0036371 |
protein localization to M-band(GO:0036309) protein localization to T-tubule(GO:0036371) |
| 0.2 |
0.7 |
GO:0001827 |
inner cell mass cell fate commitment(GO:0001827) |
| 0.2 |
0.6 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) synaptic vesicle lumen acidification(GO:0097401) |
| 0.2 |
1.0 |
GO:0048133 |
NK T cell differentiation(GO:0001865) germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) germline stem cell asymmetric division(GO:0098728) |
| 0.2 |
0.8 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.2 |
1.5 |
GO:0032625 |
interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
| 0.2 |
1.1 |
GO:0048840 |
otolith development(GO:0048840) |
| 0.2 |
2.4 |
GO:1901898 |
negative regulation of relaxation of muscle(GO:1901078) negative regulation of relaxation of cardiac muscle(GO:1901898) |
| 0.2 |
0.9 |
GO:0021631 |
optic nerve morphogenesis(GO:0021631) |
| 0.2 |
3.3 |
GO:0097094 |
craniofacial suture morphogenesis(GO:0097094) |
| 0.2 |
1.0 |
GO:0051694 |
pointed-end actin filament capping(GO:0051694) |
| 0.2 |
0.6 |
GO:1902260 |
negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
| 0.2 |
6.5 |
GO:0006376 |
mRNA splice site selection(GO:0006376) |
| 0.2 |
2.3 |
GO:0021860 |
pyramidal neuron development(GO:0021860) |
| 0.1 |
0.3 |
GO:0061470 |
T follicular helper cell differentiation(GO:0061470) |
| 0.1 |
0.4 |
GO:0071492 |
cellular response to UV-A(GO:0071492) |
| 0.1 |
0.4 |
GO:2000616 |
negative regulation of histone H3-K9 acetylation(GO:2000616) |
| 0.1 |
1.2 |
GO:0051574 |
positive regulation of histone H3-K9 methylation(GO:0051574) |
| 0.1 |
0.4 |
GO:0097278 |
complement-dependent cytotoxicity(GO:0097278) |
| 0.1 |
0.8 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.1 |
0.5 |
GO:0046543 |
development of secondary female sexual characteristics(GO:0046543) |
| 0.1 |
0.5 |
GO:0035063 |
nuclear speck organization(GO:0035063) |
| 0.1 |
0.4 |
GO:0045659 |
regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
| 0.1 |
1.1 |
GO:0035887 |
aortic smooth muscle cell differentiation(GO:0035887) |
| 0.1 |
0.6 |
GO:0071476 |
cellular hypotonic response(GO:0071476) |
| 0.1 |
0.6 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.1 |
0.7 |
GO:1902897 |
regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 |
0.3 |
GO:0019074 |
viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
| 0.1 |
0.9 |
GO:0033184 |
positive regulation of histone ubiquitination(GO:0033184) |
| 0.1 |
0.6 |
GO:0071787 |
endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 |
1.5 |
GO:0032808 |
lacrimal gland development(GO:0032808) |
| 0.1 |
0.8 |
GO:0034720 |
histone H3-K4 demethylation(GO:0034720) |
| 0.1 |
0.4 |
GO:0008627 |
intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) |
| 0.1 |
2.8 |
GO:0010971 |
positive regulation of G2/M transition of mitotic cell cycle(GO:0010971) |
| 0.1 |
0.3 |
GO:0097105 |
presynaptic membrane assembly(GO:0097105) |
| 0.1 |
0.5 |
GO:1901668 |
regulation of superoxide dismutase activity(GO:1901668) |
| 0.1 |
0.3 |
GO:0019676 |
ammonia assimilation cycle(GO:0019676) |
| 0.1 |
0.5 |
GO:0071883 |
activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.1 |
0.6 |
GO:0007296 |
vitellogenesis(GO:0007296) |
| 0.1 |
0.3 |
GO:2000670 |
positive regulation of dendritic cell apoptotic process(GO:2000670) |
| 0.1 |
0.8 |
GO:1901741 |
positive regulation of myoblast fusion(GO:1901741) |
| 0.1 |
0.3 |
GO:0007113 |
endomitotic cell cycle(GO:0007113) |
| 0.1 |
0.6 |
GO:0060903 |
positive regulation of meiosis I(GO:0060903) |
| 0.1 |
0.9 |
GO:2000766 |
negative regulation of cytoplasmic translation(GO:2000766) |
| 0.1 |
0.6 |
GO:0060501 |
positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
| 0.1 |
0.6 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.4 |
GO:0090164 |
asymmetric Golgi ribbon formation(GO:0090164) |
| 0.1 |
0.5 |
GO:0030322 |
stabilization of membrane potential(GO:0030322) |
| 0.1 |
0.5 |
GO:1900194 |
negative regulation of oocyte development(GO:0060283) negative regulation of oocyte maturation(GO:1900194) |
| 0.1 |
0.3 |
GO:2001271 |
negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.1 |
0.4 |
GO:0010735 |
positive regulation of transcription via serum response element binding(GO:0010735) |
| 0.1 |
0.3 |
GO:1900095 |
regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
| 0.1 |
0.3 |
GO:0018242 |
protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 |
0.7 |
GO:0033008 |
positive regulation of mast cell activation involved in immune response(GO:0033008) positive regulation of mast cell degranulation(GO:0043306) |
| 0.1 |
0.5 |
GO:0051418 |
interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
| 0.1 |
0.3 |
GO:0030423 |
targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.1 |
0.4 |
GO:0089711 |
L-glutamate transmembrane transport(GO:0089711) |
| 0.1 |
0.2 |
GO:0003365 |
establishment of cell polarity involved in ameboidal cell migration(GO:0003365) |
| 0.1 |
0.2 |
GO:0014846 |
esophagus smooth muscle contraction(GO:0014846) |
| 0.1 |
1.9 |
GO:0060074 |
synapse maturation(GO:0060074) |
| 0.1 |
0.3 |
GO:0016198 |
axon choice point recognition(GO:0016198) |
| 0.1 |
0.1 |
GO:0071550 |
death-inducing signaling complex assembly(GO:0071550) |
| 0.1 |
1.3 |
GO:0008210 |
estrogen metabolic process(GO:0008210) |
| 0.1 |
0.6 |
GO:0019368 |
fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.2 |
GO:0009597 |
detection of virus(GO:0009597) |
| 0.1 |
0.4 |
GO:0035095 |
behavioral response to nicotine(GO:0035095) |
| 0.0 |
0.6 |
GO:0031507 |
heterochromatin assembly(GO:0031507) |
| 0.0 |
0.3 |
GO:0007158 |
neuron cell-cell adhesion(GO:0007158) |
| 0.0 |
0.8 |
GO:0010225 |
response to UV-C(GO:0010225) |
| 0.0 |
0.2 |
GO:1900122 |
positive regulation of receptor binding(GO:1900122) |
| 0.0 |
0.3 |
GO:0000189 |
MAPK import into nucleus(GO:0000189) regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
| 0.0 |
0.6 |
GO:0042711 |
maternal behavior(GO:0042711) |
| 0.0 |
0.1 |
GO:0048686 |
regulation of sprouting of injured axon(GO:0048686) regulation of axon extension involved in regeneration(GO:0048690) |
| 0.0 |
0.2 |
GO:0042518 |
negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
| 0.0 |
0.2 |
GO:0090292 |
nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
| 0.0 |
0.3 |
GO:0035280 |
miRNA loading onto RISC involved in gene silencing by miRNA(GO:0035280) small RNA loading onto RISC(GO:0070922) |
| 0.0 |
0.3 |
GO:0034393 |
positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
| 0.0 |
0.8 |
GO:0005980 |
polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.0 |
2.5 |
GO:0006446 |
regulation of translational initiation(GO:0006446) |
| 0.0 |
0.8 |
GO:0014051 |
gamma-aminobutyric acid secretion(GO:0014051) |
| 0.0 |
0.4 |
GO:0021869 |
forebrain ventricular zone progenitor cell division(GO:0021869) |
| 0.0 |
1.3 |
GO:0035329 |
hippo signaling(GO:0035329) |
| 0.0 |
0.1 |
GO:0035441 |
cell migration involved in vasculogenesis(GO:0035441) |
| 0.0 |
2.7 |
GO:0010923 |
negative regulation of phosphatase activity(GO:0010923) |
| 0.0 |
1.8 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.0 |
0.6 |
GO:0034063 |
stress granule assembly(GO:0034063) |
| 0.0 |
0.2 |
GO:2000741 |
positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
| 0.0 |
0.1 |
GO:0033030 |
negative regulation of neutrophil apoptotic process(GO:0033030) |
| 0.0 |
0.2 |
GO:1902965 |
protein localization to early endosome(GO:1902946) regulation of protein localization to early endosome(GO:1902965) positive regulation of protein localization to early endosome(GO:1902966) |
| 0.0 |
0.2 |
GO:0060315 |
negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
| 0.0 |
2.3 |
GO:0043488 |
regulation of mRNA stability(GO:0043488) |
| 0.0 |
0.2 |
GO:0071169 |
establishment of protein localization to chromatin(GO:0071169) |
| 0.0 |
2.3 |
GO:0021954 |
central nervous system neuron development(GO:0021954) |
| 0.0 |
0.4 |
GO:0043252 |
sodium-independent organic anion transport(GO:0043252) |
| 0.0 |
0.1 |
GO:0019355 |
nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.0 |
0.1 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.1 |
GO:1903377 |
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.0 |
0.9 |
GO:0021591 |
ventricular system development(GO:0021591) |
| 0.0 |
0.2 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.0 |
0.3 |
GO:0046685 |
response to arsenic-containing substance(GO:0046685) |
| 0.0 |
0.7 |
GO:0036465 |
synaptic vesicle recycling(GO:0036465) |
| 0.0 |
0.4 |
GO:0006047 |
UDP-N-acetylglucosamine metabolic process(GO:0006047) |
| 0.0 |
0.6 |
GO:0031663 |
lipopolysaccharide-mediated signaling pathway(GO:0031663) |
| 0.0 |
0.5 |
GO:0048661 |
positive regulation of smooth muscle cell proliferation(GO:0048661) |
| 0.0 |
0.2 |
GO:0043984 |
histone H4-K16 acetylation(GO:0043984) |
| 0.0 |
0.2 |
GO:0006388 |
tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
| 0.0 |
0.2 |
GO:0070842 |
aggresome assembly(GO:0070842) |
| 0.0 |
0.2 |
GO:0060539 |
diaphragm development(GO:0060539) |
| 0.0 |
0.7 |
GO:0051965 |
positive regulation of synapse assembly(GO:0051965) |
| 0.0 |
0.2 |
GO:0038092 |
nodal signaling pathway(GO:0038092) |
| 0.0 |
0.4 |
GO:0048009 |
insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 |
0.4 |
GO:0043276 |
anoikis(GO:0043276) |
| 0.0 |
0.5 |
GO:0072661 |
protein targeting to plasma membrane(GO:0072661) |
| 0.0 |
1.6 |
GO:0050806 |
positive regulation of synaptic transmission(GO:0050806) |
| 0.0 |
1.4 |
GO:0098792 |
xenophagy(GO:0098792) |
| 0.0 |
0.1 |
GO:0000729 |
DNA double-strand break processing(GO:0000729) |
| 0.0 |
0.7 |
GO:0051489 |
regulation of filopodium assembly(GO:0051489) |
| 0.0 |
0.3 |
GO:0051443 |
positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
| 0.0 |
0.5 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.2 |
GO:0001967 |
suckling behavior(GO:0001967) |
| 0.0 |
0.3 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.1 |
GO:0098903 |
regulation of membrane repolarization during action potential(GO:0098903) |
| 0.0 |
0.1 |
GO:0010724 |
regulation of definitive erythrocyte differentiation(GO:0010724) |
| 0.0 |
0.0 |
GO:0014877 |
response to inactivity(GO:0014854) response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
